entity

Tyrosine hydroxylase / catecholamine synthesis

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Tyrosine hydroxylase / catecholamine synthesis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
2Hypotheses
1Analyses
0Outgoing
2Incoming
1Experiments
1Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (2)

SourceRelationTypeStr
THparticipates_ingene0.35
AADCparticipates_ingene0.35

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Multi-Target Synergy via Presynaptic Vesicle Hub Convergence 0.683 neurodegeneration What molecular mechanisms underlie Atrem
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis 0.384 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Levodopa-Induced Dyskinesias Mechanism — Experiment Design validation Neurodegeneration 0.400 0.50 human proposed $2,280,000

Related Papers (19)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Gene therapy for Parkinson's disease: current landscape, translational challenge [PMID:41837837] Evola V, Parmar MS Expert review of neurotherapeu 2026 0
Neurosurgical gene therapy for central nervous system diseases. [PMID:39191071] Patel RV, Nanda P, Richardson RM Neurotherapeutics : the journa 2024 0
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC d [PMID:34763085] Tai CH, Lee NC, Chien YH, Byrne BJ, Mura Molecular therapy : the journa 2022 0
Gene therapy restores dopamine transporter expression and ameliorates pathology [PMID:34011628] Ng J, Barral S, De La Fuente Barrigon C, Science translational medicine 2021 0
Current Clinical Applications of In Vivo Gene Therapy with AAVs. [PMID:33309881] Mendell JR, Al-Zaidy SA, Rodino-Klapac L Molecular therapy : the journa 2021 0
Targeting autophagy using small-molecule compounds to improve potential therapy [PMID:34729301] Zhang K, Zhu S, Li J, Jiang T, Feng L, P Acta pharmaceutica Sinica. B 2021 0
Graphene bilayers with a twist. [PMID:33208935] ["Andrei E", "MacDonald A"] Nature materials 2020 0
Reconstruction of cell spatial organization from single-cell RNA sequencing data [PMID:32541867] ["Ren X", "Zhong G", "Zhang Q", "Zhang L Cell research 2020 0
Gene therapy for neurodegenerative disorders: advances, insights and prospects. [PMID:32963936] Chen W, Hu Y, Ju D Acta pharmaceutica Sinica. B 2020 0
Ligand entry in human ileal bile acid-binding protein is mediated by histidine p [PMID:30886237] ["Horv\u00e1th G", "Egyed O", "Tang C", Scientific reports 2019 0
[Skin Changes in POEMS Syndrome]. [PMID:30988219] ["Kuwabara S"] Brain and nerve = Shinkei kenk 2019 0
Consensus guideline for the diagnosis and treatment of aromatic l-amino acid dec [PMID:28100251] Wassenberg T, Molero-Luis M, Jeltsch K, Orphanet journal of rare disea 2017 0
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecho [PMID:27491309] Nagatsu T, Nagatsu I Journal of neural transmission 2016 0
Large-scale meta-analysis of genome-wide association data identifies six new ris [PMID:25064009] ["Nalls M", "Pankratz N", "Lill C", "Do Nature genetics 2014 0
Reward and aversion in a heterogeneous midbrain dopamine system. [PMID:23578393] Lammel S, Lim BK, Malenka RC Neuropharmacology 2014 0
Differential modulation of innate immunity in vitro by probiotic strains of Lact [PMID:24365457] ["Luongo D", "Miyamoto J", "Bergamo P", BMC microbiology 2013 0
Antiparkinson prodrugs. [PMID:18259129] Di Stefano A, Sozio P, Cerasa LS Molecules (Basel, Switzerland) 2008 0
Altered fractionation: a fractional benefit? [PMID:16950339] Wirth Lori; Allen Aaron M; Machtay Mitch The Lancet 2006 0
Assessment of neuroimaging techniques as biomarkers of the progression of Parkin [PMID:14597329] Brooks DJ, Frey KA, Marek KL, Oakes D, P Experimental neurology 2003 0

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning Tyrosine hydroxylase / catecholamine synthesis in their description or question text

No additional research found